T-DM1

Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
FDA
drug approvals
Roche
T-DM1
Aveo
Delcath
Navidea Biopharmaceuticals
Lymphoseek
tivozanib
chemostat
Keep an Eye on These Five New Drugs in the First Quarter of 2013
Minyanville
Thu, 12/27/12 - 10:16 pm
Rytary
GSK
Impax Labs
Celgene
pomalidomide
Roche
T-DM1
Immunogen
Eliquis
Pfizer
Bristol-Myers Squibb
Biogen Idec
BG-12
ImmunoGen Is Living Life in the Fast Lane
Motley Fool
Thu, 11/8/12 - 12:07 pm
Immunogen
Roche
T-DM1
breast cancer
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
ImmunoGen Rises On Partner Roche’s Results
Bloomberg
Tue, 08/28/12 - 11:22 am
breast cancer
Roche
Immunogen
T-DM1
Roche Drug ‘Significantly’ Extended Lives In Cancer Trial
Bloomberg
Mon, 08/27/12 - 10:34 am
Roche
T-DM1
breast cancer
Analysts: Roche's armed antibody will help drive breast cancer drug sales
Fierce Biotech
Thu, 08/23/12 - 10:24 am
Roche
breast cancer
T-DM1
Protesters push FDA on breast cancer drug at BIO conference
Bizjournals.com
Wed, 06/20/12 - 12:33 pm
FDA
breast cancer
BIO Conference
T-DM1
Immunogen
Roche
ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP
Mon, 06/4/12 - 05:54 pm
Immunogen
Roche
breast cancer
T-DM1
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sun, 06/3/12 - 11:13 am
T-DM1
breast cancer
Genentech
Roche
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
ImmunoGen Rises After Drug Delays Cancer Worsening in Study
Bloomberg
Fri, 03/30/12 - 12:01 pm
Immunogen
breast cancer
Roche
T-DM1
Roche Breast Cancer Drug Delays Disease Worsening in Study
Bloomberg
Fri, 03/30/12 - 11:02 am
Roche
breast cancer
T-DM1
Herceptin
ImmunoGen CEO on New Breast Cancer Drug
CNBC
Tue, 09/27/11 - 11:23 am
breast cancer
Immunogen
T-DM1
T-DM1 Significantly Improved Progression-Free Survival Compared to Standard of Care for Previously Untreated HER2-Positive Metastatic Breast Cancer
Yahoo/GlobeNewswire
Sun, 09/25/11 - 12:57 pm
trastuzumab
T-DM1
breast cancer
Immunogen
Analyst says Immunogen's T-DM1 will become standard breast cancer treatment; rates stock 'Buy'
Yahoo/AP
Wed, 07/6/11 - 08:47 am
Immunogen
T-DM1
breast cancer
ImmunoGen's Hot Start
Motley Fool
Sat, 04/9/11 - 10:56 am
Immunogen
T-DM1
breast cancer
Herceptin
trastuzumab
Roche's T-DM1 Treatment Halted Spread of Breast Cancer in Mid-Stage Study
Bloomberg
Fri, 04/8/11 - 09:53 am
Roche
breast cancer
T-DM1

Pages